Gufic's operating margin trails healthcare peer median by 4.94 points
Interest and depreciation cut Rs 46.61 cr of operating profit to Rs 30.04 cr of pre-tax profit; the consolidated filing came after market close.
Filed 14 Aug 2026, 19:39 IST · after market close · Gufic BioSciences Ltd (GUFICBIO)
Key takeaways
- Consolidated operating margin of 17.87% was 4.94 percentage points below the 22.81% median for 74 reported Healthcare peers.
- Interest expense of Rs 9.32 cr and depreciation of Rs 7.71 cr reduced operating profit of Rs 46.61 cr to profit before tax of Rs 30.04 cr.
- Other income was only Rs 0.46 cr against profit before tax of Rs 30.04 cr, so net profit of Rs 22.31 cr was not materially supported by non-operating income.
Price around the results
Operating margin sits below the Healthcare peer median
Gufic's consolidated operating margin of 17.87% was 4.94 percentage points below the 22.81% median among 74 Healthcare companies that have reported. It ranked 20th from the bottom in that comparison, putting cost absorption ahead of revenue growth as the key operating issue to track.
Interest and depreciation weigh on profit conversion
Interest of Rs 9.32 cr and depreciation of Rs 7.71 cr absorbed a substantial part of the Rs 46.61 cr operating profit before profit before tax reached Rs 30.04 cr. Other income of Rs 0.46 cr was small relative to pre-tax profit, so reported earnings were primarily driven by the operating business rather than non-operating income.
No immediate stock reaction after the filing
Gufic filed its consolidated Q1FY27 results after market close on 14 August 2026, leaving no immediate market reaction to assess. The next price response will need to be read against the 17.87% operating margin and the Rs 9.32 cr interest burden.
Q1FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 |
|---|---|
| Revenue | ₹261 cr |
| Other income | ₹0 cr |
| Expenses | ₹214 cr |
| Operating profit | ₹47 cr |
| Operating margin (%) | 17.87% |
| Interest | ₹9 cr |
| Depreciation | ₹8 cr |
| Profit before tax | ₹30 cr |
| Tax | ₹8 cr |
| Net profit | ₹22 cr |
| EPS (₹) | ₹2.22 |
Operating margin of 17.87% compares with a Healthcare sector median of 22.81% across 74 peers that have reported Q1FY27.
What to watch
- Whether consolidated operating margin moves above 17.87% and toward the 22.81% Healthcare peer median.
- Whether interest expense stays at or below Rs 9.32 cr as operating profit changes.
- Whether other income remains limited relative to Rs 0.46 cr, keeping earnings tied to operations.